APA (7th ed.) Citation

Akhavanpoor, M., Gleißner, C. A., Gorbatsch, S., Dösch, A., Akhavanpoor, H., Wangler, S., . . . Erbel, C. (2014). CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions. Drug design, development and therapy, 8, . https://doi.org/10.2147/DDDT.S72394

Chicago Style (17th ed.) Citation

Akhavanpoor, Mohammadreza, et al. "CCL19 and CCL21 Modulate the Inflammatory Milieu in Atherosclerotic Lesions." Drug Design, Development and Therapy 8 (2014). https://doi.org/10.2147/DDDT.S72394.

MLA (9th ed.) Citation

Akhavanpoor, Mohammadreza, et al. "CCL19 and CCL21 Modulate the Inflammatory Milieu in Atherosclerotic Lesions." Drug Design, Development and Therapy, vol. 8, 2014, https://doi.org/10.2147/DDDT.S72394.